Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Telecom & IT > Software > Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets
Category
Telecom & IT (11451)
Broadband (398)
Contact Centers (153)
Contents (612)
Convergence (197)
Data Center (351)
Digital Broadcasting (310)
E-commerce (204)
IT Outsourcing (321)
IT Security (496)
LBS (151)
Mobile Device (721)
Mobile Subscribers (128)
Network (632)
Network & Access Devices (256)
Next Generation Wireless Com (538)
NFC (148)
Online Marketing (138)
Operator Company Profile (766)
Optical Network (266)
RFID (250)
Satellite Telecom (130)
Set-Top Box (61)
Software (1025)
UC (299)
Web-Service (487)
Wireless LAN/WiMAX (547)
Market Research Report

Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets

Published by Frost & Sullivan
Published December, 2008 Product code 79479
Content info 96 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets published by Frost & Sullivan in December, 2008. This report consists of 96 Pages and the price starts from US $ 6000.

Introduction

Abstract

This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifying critical road blocks in the growth of the Sci-BI market. A step by step analysis of the R&D cost distribution in pharma/biotech was carried out together with a competitive landscape analysis of the different players in this niche market segment.

Table of Contents

1. INTRODUCTION

Title Page

  • Title Page

Disclaimer

  • Disclaimer

Certification

  • Certification

Table of Contents

  • Table of Contents

Notes on Methodology

  • Notes on Methodology

2. MARKET INTRODUCTION AND SEGMENTATION

Introduction

  • Introduction

Segmentation

  • Segmentation

3. MAJOR GLOBAL TRENDS IN HEALTHCARE

Major Global Healthcare Trends

  • Major Global Healthcare Trends

4. CURRENT INDUSTRY TRENDS IN SCI-BI

Current Industry Trends in Sci-BI

  • Current Industry Trends in Sci-BI

5. SCI-BI DRIVERS AND RESTRAINTS

Overall Market Drivers and Restraints

  • Overall Market Drivers and Restraints

Sci-BI Drivers

  • Drivers for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015

Sci-BI Restraints

  • Restraints for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015

6. SCI-BI OPPORTUNITY ANALYSIS

Opportunity Analysis - Major Areas of Convergence

  • Opportunity Analysis - Major Areas of Convergence

Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management

  • Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management

7. PHARMA/BIOTECH R&D & SCI-BI

The ROI Challenge for Pharma

  • The ROI Challenge for Pharma

Pharmaceutical R&D Expenditure

  • Pharmaceutical R&D Expenditure

End to End Sci-BI Services

  • End to End Sci-BI Services

8. SCI-BI MARKETS COMPETITIVE LANDSCAPE

Sci-BI Markets: Competitive Landscape

  • Competitive Analysis by Company

9. CHALLENGES AND CONCLUSIONS

Challenges & Conclusions

  • Challenges & Conclusions

10. ABOUT FROST & SULLIVAN

About Frost & Sullivan

  • About Frost & Sullivan
Back to Top